Cargando…

In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers

PURPOSE: To determine risk factors for coronavirus disease 2019 (COVID-19) in healthcare workers (HCWs), characterize symptoms, and evaluate preventive measures against SARS-CoV-2 spread in hospitals. METHODS: In a cross-sectional study conducted between May 27 and August 12, 2020, after the first w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wratil, Paul R., Schmacke, Niklas A., Osterman, Andreas, Weinberger, Tobias, Rech, Jochen, Karakoc, Burak, Zeilberger, Mira, Steffen, Julius, Mueller, Tonina T., Spaeth, Patricia M., Stern, Marcel, Albanese, Manuel, Thun, Hella, Reinbold, Julia, Sandmeyer, Benedikt, Kressirer, Philipp, Grabein, Béatrice, Falkai, Peter, Adorjan, Kristina, Hornung, Veit, Kaderali, Lars, Klein, Matthias, Keppler, Oliver T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354838/
https://www.ncbi.nlm.nih.gov/pubmed/34379308
http://dx.doi.org/10.1007/s15010-021-01672-z
Descripción
Sumario:PURPOSE: To determine risk factors for coronavirus disease 2019 (COVID-19) in healthcare workers (HCWs), characterize symptoms, and evaluate preventive measures against SARS-CoV-2 spread in hospitals. METHODS: In a cross-sectional study conducted between May 27 and August 12, 2020, after the first wave of the COVID-19 pandemic, we obtained serological, epidemiological, occupational as well as COVID-19-related data at a quaternary care, multicenter hospital in Munich, Germany. RESULTS: 7554 HCWs participated, 2.2% of whom tested positive for anti-SARS-CoV-2 antibodies. Multivariate analysis revealed increased COVID-19 risk for nurses (3.1% seropositivity, 95% CI 2.5–3.9%, p = 0.012), staff working on COVID-19 units (4.6% seropositivity, 95% CI 3.2–6.5%, p = 0.032), males (2.4% seropositivity, 95% CI 1.8–3.2%, p = 0.019), and HCWs reporting high-risk exposures to infected patients (5.5% seropositivity, 95% CI 4.0–7.5%, p = 0.0022) or outside of work (12.0% seropositivity, 95% CI 8.0–17.4%, p < 0.0001). Smoking was a protective factor (1.1% seropositivity, 95% CI 0.7–1.8% p = 0.00018) and the symptom taste disorder was strongly associated with COVID-19 (29.8% seropositivity, 95% CI 24.3–35.8%, p < 0.0001). An unbiased decision tree identified subgroups with different risk profiles. Working from home as a preventive measure did not protect against SARS-CoV-2 infection. A PCR-testing strategy focused on symptoms and high-risk exposures detected all larger COVID-19 outbreaks. CONCLUSION: Awareness of the identified COVID-19 risk factors and successful surveillance strategies are key to protecting HCWs against SARS-CoV-2, especially in settings with limited vaccination capacities or reduced vaccine efficacy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01672-z.